Cliff Asness’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$151K Buy
+12,343
New +$185K ﹤0.01% 3936
2021
Q4
– Sell
-13,614
Closed -$242K – 2211
2021
Q3
$242K Buy
+13,614
New +$255K ﹤0.01% 2101

Other funds holding CLPT

Cliff Asness's CLPT Position: Q3 2026 in Review

Cliff Asness opened a new position in ClearPoint Neuro (CLPT) in Q3 2026: 12,343 shares worth $151K. The stake represents ﹤0.01% of the portfolio and ranks #3936 among its holdings. This is a return to the name: Cliff Asness previously reported a position in CLPT as recently as Q3 2021.

Cliff Asness first reported a position in CLPT in Q3 2021 and has held it in 2 quarters since. The position peaked at $242K in Q3 2021. 126 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • Cliff Asness held 12,343 shares of ClearPoint Neuro worth $151K as of Q3 2026.
  • ClearPoint Neuro was a new Cliff Asness position in Q3 2026.
  • ClearPoint Neuro made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #3936 holding.
  • Cliff Asness first reported a position in ClearPoint Neuro in Q3 2021 and has held it in 2 quarters since.
  • Cliff Asness's ClearPoint Neuro position peaked at $242K in Q3 2021.
  • 126 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.